Potent agonist of muscarinic receptors
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Xanomeline (oxalate)

Item No. 10790

Technical Information
Formal Name
3-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-pyridine, ethanedioate
CAS Number
141064-23-5
Synonyms
  • Lumeron
  • LY246708
  • Memcor
Molecular Formula
C14H23N3OS • C2H2O4
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 1.6 mg/mlDMF:PBS (pH 7.2) (1:9): 0.1 mg/ml
λmax
223, 296 nm
SMILES
CCCCCCOC1=NSN=C1C2=CCCN(C)C2.OC(C(O)=O)=O
InChi Code
InChI=1S/C14H23N3OS.C2H2O4/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12;3-1(4)2(5)6/h8H,3-7,9-11H2,1-2H3;(H,3,4)(H,5,6)
InChi Key
ZJOUESNWCLASJP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Xanomeline (oxalate) is a potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively).1 It has antipsychotic-like activities in rats and Cebus monkeys.2,3 M1 selective agonists, like Xanomeline (oxalate), enhance memory function and has utility in treating Alzheimer’s Disease.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Heinrich, J.N., Butera, J.A., Carrick, T., et alPharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists. Eur. J. Pharmacol. 605(1-3), 53-56 (2009).

    2. Stanhope, K.J., Mirza, N.R., Dickerdike, M.J., et alThe muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. J. Pharmacol. Exp. Ther. 299(2), 782-792.

    3. Andersen, M.B., Fink-Jensen, A., Peacock, L., et alThe muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys. Neuropsychopharmacology 28(6), 1168-1175 (2003).

    4. Messer, W.S., Jr. The utility of muscarinic agonists in the treatment of Alzheimer’s disease. J. Mol. Neurosci. 19(1-2), 187-193 (2002).